Following this transaction, Gardner retains direct ownership of 21,358 shares in the company. The sale price for the shares ranged between $59.00 and $59.70 per share. The company maintains strong financial health with a GREAT overall score and trades at an attractive P/E ratio of 8.8. InvestingPro subscribers can access 10 additional investment tips and comprehensive financial metrics for Kewaunee Scientific. The company maintains strong financial health with a GREAT overall score and trades at an attractive P/E ratio of 8.8. InvestingPro subscribers can access 10 additional investment tips and comprehensive financial metrics for Kewaunee Scientific.
Following this transaction, Gardner retains direct ownership of 21,358 shares in the company. The sale price for the shares ranged between $59.00 and $59.70 per share.
In other recent news, Kewaunee Scientific Corporation has made a strategic expansion by acquiring Minneapolis-based Nu Aire for $55 million. This acquisition is expected to enhance Kewaunee's market presence and diversify its product portfolio. Nu Aire, known for its expertise in biological safety cabinets and various laboratory equipment, brings a robust customer base from life sciences, healthcare, and education sectors.
In the wake of this acquisition, Nu Aire's President, Bill Peters, will maintain his role and join Kewaunee's corporate management team. This development is anticipated to create operational synergies and foster sustainable growth for Kewaunee.
In other developments, Kewaunee confirmed the re-election of Mr. Keith M. Gehl as a Class II director during its Annual Meeting of Shareholders. The appointment of Forvis Mazars, LLP as the company’s independent auditors for the fiscal year 2025 was also ratified. These are among the recent updates from the corporation.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.